Drug · DIN 02495430
MINT-APIXABAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 17, 2023; first marketed April 17, 2023.
- Drug Identification Number (DIN)
- 02495430
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Apixaban B01AF02
- Class
- Human
- Record last updated
- June 4, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APIXABAN | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 20, 2022: NOC 29091Abbreviated New Drug Submission (ANDS)
Other DINs named MINT-APIXABAN
- DIN 02495449 · Marketed